Joslyne Elsa Aceves Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12141 Brookhurst St Ste 101, Garden Grove, CA 92840 Phone: 714-296-1934 |
Jaqueline Mendoza Nunez Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12966 Euclid St Ste 280, Garden Grove, CA 92840 Phone: 714-823-4770 Fax: 714-823-4777 |
Frances Cecile Roberts, ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12141 Brookhurst St Ste 101, Garden Grove, CA 92840 Phone: 562-706-9807 |
Carl Edward Johnson, MSW,LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12842 Valley View St, Ste #101, Garden Grove, CA 92845 Phone: 714-490-4952 Fax: 714-895-8667 |
News Archive
Biotechnology industry leaders announced today a major new program to improve the quality of U.S. life science education. The Biotechnology Institute's new "Scientists in the Classroom" initiative is the life science industry's response to President Obama's "Educate to Innovate" campaign to improve the performance of America's students in science, technology, engineering, and mathematics (STEM) education.
Macrophages are white blood cells that, depending on the signals they get from the immune system, become specialized in either increasing or decreasing inflammation.
If physical distancing measures in Ontario are relaxed too much or too quickly, the province could see hospitals overwhelmed with COVID-19 patients as well as exponential growth in deaths, concludes new research involving a University of Guelph infectious disease modeller.
A receptor, first known for its role in mediating the harmful effects of the environmental pollutant dioxin in our body, is now understood to play other important roles in modulating the innate immune response.
MannKind Corporation today announced that it has entered into a previously announced stock lending agreement pursuant to which it will lend 9,000,000 shares of its common stock to Bank of America, N.A. MannKind has also entered into an underwriting agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), an affiliate of Bank of America, pursuant to which Merrill Lynch will sell the shares at an offering price of $5.55 per share.
› Verified 7 days ago